Signaling pathways
-
BA4891 UpadacitinibSummary: Upadacitinib (ABT-494) is a potent, orally active, selective Janus kinase 1 inhibitor. -
BA4892 ButyzamideSummary: Butyzamide is an orally effective activator of a thrombopoietin (TPO) receptor. -
BA4893 AbrocitinibSummary: Abrocitinib (PF-04965842) is a potent, orally available, selective inhibitor. - BA4895 ItacitinibSummary: Itacitinib (INCB039110) is a potent, selective inhibitor.
-
BA4896 DelgocitinibSummary: A specific inhibitor. - BA4897 BMS-986202Summary: BMS-986202 is a potent, selective, and orally active inhibitor.
- BA4898 VVD-118313Summary: VVD-118313 is a potent and selective inhibitor.
- BA4899 PovorcitinibSummary: Povorcitinib (INCB54707) is a potent and selective inhibitor effective in reducing abscesses and inflammatory nodules.
- BA4900 SAR-20347Summary: An inhibitor.
- BA4901 IzencitinibSummary: Izencitinib (TD-1473) is an orally active, non-selective, gut-limited inhibitor.